(VIANEWS) – GJENSIDIGE FORSIKR (GJF.OL), UCB (UCB.BR), PATRIMOINE ET COMM (PAT.PA) are the highest payout ratio stocks on this list.
We have gathered information about stocks with the highest payout ratio so far. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. GJENSIDIGE FORSIKR (GJF.OL)
85.18% Payout Ratio
Gjensidige Forsikring ASA provides general insurance and pension products in Norway, Sweden, Denmark, Latvia, Lithuania, and Estonia. The company operates through six segments: General Insurance Private, General Insurance Commercial, General Insurance Denmark, General Insurance Sweden, General Insurance Baltics, and Pension. It offers motor, accident and health, travel, leisure craft, valuables, liability, commercial, marine/transport, agriculture, natural perils, life, and pet insurance products. The company also provides defined contribution occupational pension schemes for businesses, which include disability pension, spouse/cohabitant pension, and child's pension products. It distributes its products through various distribution channels comprising office channel, call center, Internet, partners, and brokers to private and commercial customers. The company was founded in 1816 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, GJENSIDIGE FORSIKR has a trailing twelve months EPS of kr13.55.
PE Ratio
GJENSIDIGE FORSIKR has a trailing twelve months price to earnings ratio of 12.62. Meaning, the purchaser of the share is investing kr12.62 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.89%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Mar 24, 2023, the estimated forward annual dividend rate is 8.25 and the estimated forward annual dividend yield is 4.82%.
Yearly Top and Bottom Value
GJENSIDIGE FORSIKR’s stock is valued at kr171.00 at 17:10 EST, way under its 52-week high of kr223.60 and above its 52-week low of kr164.50.
More news about GJENSIDIGE FORSIKR.
2. UCB (UCB.BR)
60.47% Payout Ratio
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; BIMZELX for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition, the company is involved in developing rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis and immune-mediated necrotizing myopathy; staccato alprazolam to treat tereotypical prolonged seizure; Bepranemab to treat Alzheimer's disease; and UCB0599 to treat Parkinson's disease. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, Otsuka, and doc.ai. It operates in the United States, Japan, Germany, rest of Europe, Spain, France, China, Italy, the United Kingdom, Ireland, Belgium, and internationally. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, UCB has a trailing twelve months EPS of €3.77.
PE Ratio
UCB has a trailing twelve months price to earnings ratio of 22.09. Meaning, the purchaser of the share is investing €22.09 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.81%.
More news about UCB.
3. PATRIMOINE ET COMM (PAT.PA)
40.98% Payout Ratio
Patrimoine et Commerce SA, a real estate company, engages in the acquisition, development, and operation of commercial real estate properties in France. The company operates a portfolio of 31 real estate assets covering a total area of 129,280 square meters located in high-attraction areas in the suburbs or centers of medium-sized cities. Its property portfolio includes shopping malls, supermarkets, shops, and business parks. The company is based in Boulogne-Billancourt, France.
Earnings Per Share
As for profitability, PATRIMOINE ET COMM has a trailing twelve months EPS of €3.03.
PE Ratio
PATRIMOINE ET COMM has a trailing twelve months price to earnings ratio of 6.02. Meaning, the purchaser of the share is investing €6.02 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.74%.
Moving Average
PATRIMOINE ET COMM’s worth is higher than its 50-day moving average of €17.29 and way higher than its 200-day moving average of €16.48.
Yearly Top and Bottom Value
PATRIMOINE ET COMM’s stock is valued at €18.25 at 17:10 EST, below its 52-week high of €19.50 and way higher than its 52-week low of €14.45.
Sales Growth
PATRIMOINE ET COMM’s sales growth for the current quarter is 9%.
Volume
Today’s last reported volume for PATRIMOINE ET COMM is 1523 which is 31.17% below its average volume of 2213.
More news about PATRIMOINE ET COMM.
4. REMY COINTREAU (RCO.PA)
31.73% Payout Ratio
Rémy Cointreau SA, together with its subsidiaries, engages in the production, sale, and distribution of liqueurs and spirits. The company operates through Rémy Martin, Liqueurs & Spirits, and Partner Brands segments. It offers liqueurs, brandy, gin, single malt whisky, rum, wine, and champagne primarily under the Cointreau, Metaxa, St-Rémy, Mount Gay, Bruichladdich, Port Charlotte, Octomore, The Botanist, Westland, LOUIS XIII, and Domaine des Hautes Glaces brands. The company operates in Europe, the Middle East, Africa, the Americas, Asia, Australia, and New Zealand. Rémy Cointreau SA was founded in 1724 and is headquartered in Cognac, France.
Earnings Per Share
As for profitability, REMY COINTREAU has a trailing twelve months EPS of €1.67.
PE Ratio
REMY COINTREAU has a trailing twelve months price to earnings ratio of 100.72. Meaning, the purchaser of the share is investing €100.72 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.16%.
Yearly Top and Bottom Value
REMY COINTREAU’s stock is valued at €168.40 at 17:10 EST, way under its 52-week high of €198.60 and way above its 52-week low of €151.00.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jul 27, 2022, the estimated forward annual dividend rate is 1.85 and the estimated forward annual dividend yield is 1.1%.
Moving Average
REMY COINTREAU’s worth is below its 50-day moving average of €169.33 and under its 200-day moving average of €171.01.
More news about REMY COINTREAU.
